Shares of The Scotts Miracle-Gro Company (NYSE:SMG – Get Rating) have been assigned a consensus recommendation of “Hold” from the nine ratings firms that are covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $76.29.
Several analysts have recently commented on SMG shares. StockNews.com upgraded Scotts Miracle-Gro from a “sell” rating to a “hold” rating in a research note on Wednesday, May 17th. UBS Group cut their price target on shares of Scotts Miracle-Gro from $80.00 to $70.00 in a report on Friday, May 5th. Barclays cut Scotts Miracle-Gro from an “overweight” rating to an “equal weight” rating and dropped their price target for the company from $105.00 to $70.00 in a research report on Wednesday, April 26th. JPMorgan Chase & Co. raised Scotts Miracle-Gro from a “neutral” rating to an “overweight” rating and set a $80.00 price objective on the stock in a report on Monday, May 8th. Finally, Truist Financial lowered their target price on shares of Scotts Miracle-Gro from $70.00 to $65.00 in a research note on Thursday, May 4th.
In related news, CEO James Hagedorn sold 25,000 shares of the stock in a transaction dated Friday, May 12th. The shares were sold at an average price of $67.00, for a total value of $1,675,000.00. Following the sale, the chief executive officer now directly owns 179,899 shares of the company’s stock, valued at approximately $12,053,233. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 27.28% of the company’s stock.
Institutional Trading of Scotts Miracle-Gro
Scotts Miracle-Gro Stock Performance
NYSE SMG opened at $68.57 on Wednesday. The firm has a 50-day moving average of $70.22 and a 200-day moving average of $66.12. The company has a debt-to-equity ratio of 22.82, a quick ratio of 1.25 and a current ratio of 2.07. The stock has a market cap of $3.84 billion, a PE ratio of -6.12 and a beta of 1.63. Scotts Miracle-Gro has a 52-week low of $39.06 and a 52-week high of $102.25.
Scotts Miracle-Gro (NYSE:SMG – Get Rating) last posted its quarterly earnings results on Wednesday, May 3rd. The basic materials company reported $3.78 EPS for the quarter, topping analysts’ consensus estimates of $3.20 by $0.58. Scotts Miracle-Gro had a positive return on equity of 81.02% and a negative net margin of 16.57%. The company had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.61 billion. During the same quarter in the previous year, the firm earned $5.03 EPS. Scotts Miracle-Gro’s revenue was down 8.8% on a year-over-year basis. On average, sell-side analysts anticipate that Scotts Miracle-Gro will post 2.61 EPS for the current year.
Scotts Miracle-Gro Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, June 9th. Investors of record on Friday, May 26th will be paid a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 3.85%. The ex-dividend date is Thursday, May 25th. Scotts Miracle-Gro’s payout ratio is presently -23.55%.
Scotts Miracle-Gro Company Profile
Scotts Miracle-Gro Co engages in the manufacturing, marketing, and sale of products for lawn and garden care and indoor and hydroponic gardening. Its products and services include lawn care, gardening and landscape, hydroponic hardware and growing environments, lighting, controls, and marketing agreement.
- Get a free copy of the StockNews.com research report on Scotts Miracle-Gro (SMG)
- Airline ETFs: What They Are and How to Invest
- Williams-Sonoma Is The Retail Value Play, Here’s Why
- Ladder Corporation: Climbing Higher And Paying 9% Yield
- Microbot Medical spikes 150% on its Endovascular Surgical Robot
- PetMed Express: Charts Say This Could Be The Bottom
Receive News & Ratings for Scotts Miracle-Gro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scotts Miracle-Gro and related companies with MarketBeat.com's FREE daily email newsletter.